Cystatin C is a superior glomerular filtration rate (GFR) marker for the diagnosis and therapeutic control of renal function, as a reduction in the GFR causes a rise in the concentration of cystatin C. In this webinar Dr. Erling Sundrehagen, the co-founder of Gentian and the company’s CSO, will elaborate on the following topics:
- Determining Glomerular Filtration Rate (GFR)
- The history of cystatin C
- Properties of cystatin C and its clinical value
- Interference and avian antibodies
- The benefits of the Gentian Cystatin C immunoassay
- Cystatin C in addition to creatinine
Watch the webinar here
The Gentian Cystatin C Immunoassay
The Gentian Cystatin C Immunoassay was Gentian’s first product and was launched in 2006, filling the significant gap in the IVD market for a high quality, sensitive, turbidimetric cystatin C immunoassay.
- ERM-DA471/IFCC standardised
- FDA510 (k) cleared and CE-marked
- Available for a wide range of clinical analysers with documented high inter instrument accuracy1
- One of the methods used to evaluate the commutability of the World standard produced by IFCC2
- Particle-Enhanced Turbidimetric Immunoassay (PETIA)
Contact us
Please send an email to marketing@gentian.com or fill out the form below to get in touch with Product Manager for cystatin C
References
- Eckfeldt JH et al. Arch Pathol Lab Med 2015;139:888-93
- Grubb A et al. Clin Chem Lab Med 2010;48: 16-19
